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Alopecia areata represents an autoimmune pathological process driven pri-
marily by cellular aberrations contained within the immune system, which activates 
various humoral and cellular elements of the immune response. The aim of this 
study was to determine the mRNA expression levels of T-bet and GATA-3 as poten-
tial inducers of T helper (Th)1 and Th2 differentiation, respectively, as well as 
Th1(IFN-γ) and Th2(IL-4) cytokine mRNA expression in patients with alopecia ar-
eata. Using real-time reverse transcriptase PCR (RT-PCR), the relative amounts of 
T-bet, GATA-3, IFN-γ, and IL-4 mRNA transcripts were determined in PBMCs 
from 20 Iranian patients with alopecia areata and compared with those of 20 healthy 
control subjects. In comparison with the normal group, T-bet and IFN-γ mRNA ex-
pression levels were signifi cantly up-regulated in the alopecia areata patients, while 
GATA-3 and IL-4 mRNA expression levels were down-regulated. Notably, positive 
correlation (P < 0.05) was found between IFN-γ and T-bet levels in patients and 
controls. In addition, signifi cant positive correlations existed between GATA-3 and 
IL-4 (P < 0.05). These results indicate that a Th1/Th2 imbalance exists in alopecia 
areata, and it may be implicated in the pathogenesis of disease.
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Introduction
Alopecia areata (AA) is a common, chronic, infl ammatory disorder which 
typically causes an unpredictable, non-scarring form of hair loss and affects al-
most 0.1% of the general population [1]. Although the aetiology of AA is poorly 
understood, current evidence proposes that alterations in T-cell subpopulations 
and abnormality of their cytokine expression may contribute to the disease patho-
genesis [2]. Therefore, one of the most important issues in the proper interpreta-
tion of the immunological alterations in AA is to determine the variations of 
 T-lymphocyte subsets in affected patients.
In humans, different T-cell subpopulations can be recognized in peripheral 
blood and other tissues on the basis of molecular markers and distinct cytokine 
profi les. Among those, special attention has been paid to two types of function-
ally different CD4+ T helper cell subsets known as T helper 1 (Th1) and T helper 
2 (Th2).
Increased or unbalanced activation of Th1 or Th2 subgroups, not only com-
promise normal immune system function and haemostasis but also promote and 
support the development of AA. However, there is controversy in the literature 
about AA being a Th1 or Th2 autoimmune phenomenon, or both [3–6]. Thus, 
identifying the molecular switches that regulate differentiation of CD4+ T cells 
into Th1 and Th2 effector cells in diseased subjects is the keystone for the char-
acterization of the errors in the function of the immune system. In another word, 
aberrations of the molecular mechanisms underlying Th differentiation may 
 affect the susceptibility to AA.
To date, the complete program of Th1/Th2 differentiation is not defi ni-
tively known. There is growing evidence to suggest that two transcription fac-
tors, T-box expressed in T cells (T-bet) and guanine adenine thymine adenine 
sequence-binding protein 3 (GATA-3), are the determining factors of Th1 and 
Th2 development, respectively [7, 8]. These cells also display a unique and differ-
ent cytokine pattern. Th1 cells that produce interferon-γ (IFN-γ), IL-2 and tu-
mour necrosis factor-β (TNF-β), are involved in cell-mediated immunity. Where-
as Th2 cells enhance humoral responses and their activities are accompanied by 
the production of cytokines such as IL-4, IL-5, IL-13 and IL-10 [9]. In addition, 
these lymphocyte groups have counterregulatory effects against each other pre-
dominantly by means of the IL-4-IFN-γ negative feedback loop [10].
The goal of this research was, (1) to determine T-bet, GATA-3, IFN-γ, and 
IL-4 mRNA expression patterns in PBMCs of patients with AA and healthy con-
trol subjects, (2) analysis of correlation between T-bet/GATA-3 and IFN-γ/IL-4 
to understand the potential role of these two transcription factors in signalling 
for the differentiation of Th1/Th2 lymphocytes, (3) to evaluate whether there 
 STUDY OF TH1/TH2 BALANCE 277
Acta Microbiologica et Immunologica Hungarica 62, 2015
was a difference in cytokine gene expression patterns (IFN-γ, and IL-4) among 
control group and patients.
Materials and Methods
Patients and controls
Peripheral venous blood specimens were drawn from 20 patients with AA 
(11 men, 9 women) in dermatology clinics. All of the individuals were treatment 
free for a minimum of four weeks before entering the study. All cases were ex-
amined for body involvement with alopecia areata. The pattern of hair loss was 
divided into two groups as follows: Patchy hair loss (n = 19) and alopecia totalis 
(AT: Loss of whole scalp hair; n = 1). The presentation of patients was usually 
with single or several patches of hair loss with no scales. Nail changes with pit-
ting was observed in 5 (25%) of patients.
Patients were categorized into one of three groupings according to the pres-
ence of associated disorders: 13 had no family history of autoimmune diseases 
and no other disorder, 6 had a family history of autoimmune disorder but had 
no other diseases, and 1 had an autoimmune disease (vitiligo).
The mean age of the patients in this study was 28.65±10.12 yr (men 
28.73±13.05 yr; women 28.56±5.53 yr). Blood samples from 20 healthy subjects 
(4 men, 16 women) were also used as controls, all of whom had no history of AA 
or other chronic and autoimmune diseases. The mean age of the healthy volun-
teers was 30.10±6.87 yr (men, 35±9.13 yr, women, 28.88± 5.92 yr).
The protocol was approved by the Research Ethics Board at Tehran Univer-
sity of Medical Sciences. All patients and control subjects had completed in-
formed consent before the start of any study-related procedures.
Plasma was separated by centrifugation at 4 °C, aliquoted, and stored at 
–70 °C, until assayed. The stored plasma was used later for quantifying IFN-γ 
and IL-4. PBMCs were isolated from the whole blood by standard density gradi-
ent centrifugation using Histopaque (Pharmacia, Uppsala, Sweden) gradient.
Isolation of RNA from PBMCs and reverse transcription
Approximately 5 ml of fresh EDTA whole blood was collected from pa-
tients with AA and normal controls. Total RNA was extracted from PBMCs 
 using RibospinTM (GeneALL, Seoul, Korea). In the next step, the yield and qual-
ity of the recovered RNA samples was assessed by agarose gel electrophoresis 
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and ethidium bromide staining. In addition, the concentration of RNA was esti-
mated by measuring the absorbance at 260/280 nm in the Nanodrop (Thermo 
Scientifi c, USA). Only high-quality RNA, with the absorbance ratio between 200 
and 400 ng/μl, was used for further experiments.
The fi rst strand cDNA was generated from approximately 1000 ng of RNA 
using the fi rst strand cDNA synthesis kit (Fermentas, Germany) and stored fro-
zen at –20 ºC until use.
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) 
analysis
SYBR Green I-based one-step real-time quantitative RT-PCR amplifi ca-
tion was performed in a RotorGene 6000 (Corbett Life Science, Australia) ther-
mal cycler. We confi rmed that non-specifi c bands were not detected by melting 
curve analysis for each primer set. Primers specifi c for T-bet, GATA-3, IFN-γ, 
IL-4 and housekeeping gene B-actin were purchased from TAG Copenhagen 
(Denmark). B-actin gene was used as an internal control to normalize the expres-
sion of these genes. The nucleotide sequences of the primers and RT-PCR proto-
cols utilized in this study was explained previously [11].
PCR products were then electrophoresed on an agarose gel in order to de-
termine the presence of a single band with the expected size. Quantitative gene 
expression data were normalized to the expression levels of the house-keeping 
B-actin gene. For this reason, Ct (cycle threshold) value that represents the cycle 
number in which the PCR products reach the threshold level was applied. The 
expression level of the target genes were shown as ΔCt (ΔCt = Ct value of the 
target gene – Ct value of the β-actin gene). All statistical analyses were carried 
out on ΔCt values. Higher ΔCT values express lower mRNA levels.
Statistical analysis
Student’s t test was used for comparing sample results with a known value. 
Correlations between the different variables were assessed by Pearson test. 
 P-values lower than 0.05 were considered statistically signifi cant. Results are 
 expressed as means±SD.
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Results
Detection of transcription factor gene expression
The expression levels of transcription factors for Th1 (T-bet) and Th2 
 (GATA-3) were directly analysed on PBMCs by means of quantitative real-time 
PCR (Figs 1 and 2). This revealed a signifi cantly higher T-bet mRNA expression 
level in patients’ PBMCs (–1.25±5.13) compared with controls (5.04±4.70). On the 
contrary, reduced GATA-3 expression was observed in patients’ samples 
(4.29±3.83) compared with controls (1.74±5.19).
Figure 1. mRNA expression levels for T-bet in patients and control subjects. 
β-actin was used as the internal control. 
Please note that a higher ΔCt value corresponds to a comparably lower expression level
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Figure 2. mRNA expression levels for GATA-3 in patients and control subjects. 
β-actin was used as the internal control. 
Please note that a higher ΔCt value corresponds to a comparably lower expression level
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Detection of cytokine gene expression
Differences in Th1/Th2 cytokine pattern were assessed at the mRNA level 
between patients and controls (Figs 3 and 4). To explore the role of IFN-γ and 
IL-4 in Th mediated autoimmune pathology of AA, we evaluated the variations 
of mRNA levels of Th1-type cytokine (IFN-γ) and Th2-type cytokine (IL-4) in 
patients and controls. As indicated in Fig. 3, the level of IFN-γ mRNA were sig-
nifi cantly increased in patients (–2.24±3.40) compared with healthy subjects 
(2.80±4.26) (P < 0.05). In contrast, IL-4 mRNAs were signifi cantly reduced in 
the PBMCs from patients (4.11±4.85) as compared to normal controls (1.02±3.87). 
Figure 3. mRNA expression levels for IFN-γ in patients and control subjects. 
β-actin was used as the internal control. 
Please note that a higher ΔCt value corresponds to a comparably lower expression level
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Figure 4. mRNA expression levels for IL-4 in patients and control subjects. 
β-actin was used as the internal control. 
Please note that a higher ΔCt value corresponds to a comparably lower expression level
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In addition, there was signifi cant positive correlation between T-bet and IFN-γ 
mRNA levels (r = 0.463, P < 0.05), and of GATA-3 with IL-4 (r = 0.635, p < 0.05). 
The same type of correlation was also observed in control subjects (P < 0.05).
Discussion
AA is a disease of the hair follicles and responsible for 0.7% to 3.8% of 
dermatology clinics visits [12]. In spite of the attempts to reveal the pathophysiol-
ogy behind this disease, it still remains an enigma. Over the years, several mech-
anisms underlying AA (such as autoimmunity, environmental factors and genetic 
predisposition) have been proposed. Among them, great attention has been fo-
cused on the autoimmunity. Multiple lines of evidence have demonstrated that 
immune system disturbances and breakdown of T cell tolerance are the key play-
ers in the pathogenesis and development of AA [13, 14]. Moreover, it is now ac-
cepted that the imbalance of Th1/Th2 immunity becomes the cause of various 
immune diseases including AA [15–17].
In another word, the aberration of Th1/Th2 ratio may be linked to the 
pathogenesis of AA. Therefore, the purpose of this study was to determine the 
expression pattern of T-bet and GATA-3 as the master regulators of Th1 and Th2 
lineage commitment, respectively. The results of our study demonstrate a sig-
nifi cant increase in T-bet mRNA expression level in PBMCs of patients com-
pared to normal controls. In addition, gene expression of GATA-3 was lower (2.5 
fold) in patients compared with healthy subjects, although this was not statisti-
cally signifi cant.
These results are in agreement with the fi ndings from other researches, 
with emphasis on the importance of Th1 cells in the pathogenesis of AA. For 
example, Nakamura et al. indicated the Th1-predominant lymphocytic infi ltra-
tion around hair follicles of patients with alopecia areata [18]. In another study, 
Ito et al. demonstrated that patients with acute AA have a higher frequency of 
circulating CXCR3+ CD4+ Th1 cells [19]. 
In other part of this study, IL-4 and IFN-γ mRNA expression level was 
evaluated. The main reason for evaluation of Th1 and Th2 cytokine mRNA tran-
scripts was the lack of clear and convincing evidence with respect to the exact 
role of these cytokines and their contributions in AA pathogenesis [20, 21].
The results of our study indicated a signifi cant increase of IFN-γ mRNA 
expression in patients compared with normal controls (p < 0.05). In contrast, 
 IL-4 mRNA expression was signifi cantly lower in patients than in control sub-
jects (p < 0.05). Furthermore, signifi cant correlation between T-bet and IFN-γ 
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mRNA expression was observed (p < 0.05). We also showed a signifi cant positive 
correlation between GATA-3 and IL-4 mRNA levels (p < 0.05).
It seems that IFN-γ is the key cytokine involved in the pathogenesis of AA 
[22] and many recent studies point to the connection between elevated levels 
of serum IFN-γ and AA [23, 24]. These fi ndings are in agreement with other 
studies demonstrating expanded population of IFN-γ expressing cells in PBMC 
of patients with AA [25].
The possible role of IFN-γ in the pathogenesis of AA is further supported 
by some murine models of skin graft-induced AA. For example, Freyschmidt-
Paul et al. carried out an impressive study on C3H/HeJ mice (a mouse model of 
AA) with and without a targeted deletion of the Th1 cytokine IFN-γ gene. Their 
results indicate that 90% of wild-type mice [IFN–γ(+/+)] developed AA, after 
grafting alopecia areata-affected skin, while none of the IFN-γ(–/–) mice exhib-
ited hair loss [26]. Moreover, it has been reported that local injections of both 
IL-4 and neutralizing anti-IFN-γ antibody effectively treated alopecia in C3H/
HeJ mice [27].
Considering the above mentioned fi ndings, it seems plausible to claim that 
IFN-γ plays a pivotal role in the pathogenesis of AA. IFN-γ may affect the dis-
ease process through multiple potential mechanisms of action, including collapse 
of the hair follicle immune privilege. It was indicated that IFN-γ is the most ef-
fective inducer of ectopic MHC class I expression in murine anagen hair bulbs in 
vivo [28]. Moreover, Paus et al. has been reported that systemic treatment of ge-
netically susceptible C3H/HeJ mice with IFN-γ accelerated development of AA. 
They proposed that disease progression may be associated with aberrant expres-
sion of MHC class I and class II in the follicular epithelium [29].
Similar to IFN-γ, evidence for the role of IL-4 in AA is complex. For in-
stance, Teraki et al. indicate increased IL-4 production in patients with the local-
ized AA [30]. Another study revealed elevated serum IL-4 and total IgE in AA 
patients (particularly alopecia universalis, AU, and chronic patients) [31]. In ad-
dition, an elevated expression of Th1 cytokines (IFN-γ) and Th2 cytokines (IL-4 
and IL-10) were observed in C3H ⁄ HeJ AA mice [32]. These fi ndings differ from 
our results demonstrating decreased production of IL-4 in patients with AA. 
However, there is some evidence in the literature for a reduction of IL-4 produc-
tion by patients and mice species that display the AA [5].
These disparities may in part depend on multiple factors such as the type of 
disease, disease activity and treatment [30–33]. These factors may affect some 
aspects of the immune system which may result in an altered Th1/Th2-balance 
and the cytokines they release. The main goal of the current study was to evalu-
ate patients with new-onset AA and who had not received any treatment at all. 
The results indicated that the mRNA expression levels of T-bet and IFN-γ were 
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strikingly elevated in the PBMCs of our patients. This suggests that Th1 bias in 
Th1/Th2 immune response may play a vital role in disease induction.
Conclusions
The current research indicates mRNA expression of Th1-specifi c tran-
scription factors (T-bet) and cytokines (IFN-γ) are predominant in the AA. As a 
result, Th1 immune responses may play an essential role in disease induction.
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